Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033079 · ClinicalTrials.gov registry record · NA
Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
A NA study of Pneumonia Childhood, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 536
- Enrollment target
- 1
- Study location
NCT06033079: Completed NA study of Pneumonia Childhood, sponsored by Vanderbilt University Medical Center.
NCT06033079 is a NA study of Pneumonia Childhood that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 536 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06033079, a NA study of Pneumonia Childhood, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 536 participants
- Enrollment target
- 1
- Study location
Study Summary
Children with pneumonia presenting to the emergency department at Monroe Carell Jr. Children's Hospital at Vanderbilt or Children's Hospital of Pittsburgh will be potentially eligible for study. During intervention periods, providers caring for enrolled children will be presented with a detailed decision support strategy that emphasizes management in accordance with national guideline recommendations. The anticipated study duration is 24 months and, as this study does not include direct contact with enrolled subjects, there is no anticipated follow up.
Primary Outcome
Number of participants who were disposed from the ED and experienced a change in level of care within 24 hours unless objective criteria present. Appropriate dispositions were defined as follows. 1. Disposition: Discharged to home, Appropriate if no subsequent hospitalization within 24h 2. Disposition: Inpatient Ward, Appropriate if hospital length of stay (LOS) ≥ 24h OR hospital LOS \< 24h with objective criteria for admission present (eg, need for supplemental oxygen) PLUS no transfer to inte
Conditions Studied
Interventions
- BEHAVIORAL Clinical Decision Support
Study Locations (1)
Tennessee
- Monroe Carell Jr. Children's Hospital - Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 536 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT06033079 record still lists
NCT06033079 is an interventional study that assigns participants to a tested intervention. The registered 536 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Pneumonia Childhood appearing as the primary indexed condition, and to 1 intervention - of which Clinical Decision Support is the first listed.
NCT06033079 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06033079 about?
NCT06033079 is a clinical study titled "Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)". Children with pneumonia presenting to the emergency department at Monroe Carell Jr. Children's Hospital at Vanderbilt or Children's Hospital of Pittsburgh will be potentially eligible for study. During intervention periods, providers caring for enrolled children will be presented with a detailed dec...
What is the current status of trial NCT06033079?
This trial is currently completed. It is a NA study. The enrollment target is 536 participants. The study started on 2020-11-20. Estimated completion is 2022-11-30.
What conditions does trial NCT06033079 study?
This clinical trial studies the following conditions: Pneumonia Childhood.
What interventions are being tested in trial NCT06033079?
The interventions under investigation include: Clinical Decision Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06033079?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06033079 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia Childhood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06033079's enrollment target sits among peer trials
536 188th of 2000 higher than 1,813 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05880004 · 537 participants · NA
Developing a Support Application for Food Pantries (SAFPAS) to Improve Client Access to Healthy Foods & Enhance Emergency Preparedness
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
- NCT03772028 · 538 participants · Phase 3
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI